Investigation of Concurrent Pneumococcal Meningitis in Two Children Attending the Same Day-Care Center.

cluster daycare center invasive pneumococcal disease pneumococcal carriage pneumococcal meningitis

Journal

Frontiers in pediatrics
ISSN: 2296-2360
Titre abrégé: Front Pediatr
Pays: Switzerland
ID NLM: 101615492

Informations de publication

Date de publication:
2022
Historique:
received: 16 05 2022
accepted: 22 06 2022
entrez: 5 8 2022
pubmed: 6 8 2022
medline: 6 8 2022
Statut: epublish

Résumé

Only a few clusters of invasive pneumococcal disease have been described globally in children, and most of these cases occurred before pneumococcal vaccination implementation. Two unusual cases of pneumococcal meningitis, occurring in the same daycare center over a 3-day period, were reported. Both cerebrospinal fluid (CSF) were sent to the National reference center for pneumococci. In addition, we decided to perform a pneumococcal carriage study on all children and staff of the daycare center to analyze the pneumococcal serotypes circulating in this DCC and to discuss an antibiotic chemoprophylaxis. CSF culture was positive for pneumococcus, and serotype 25A was identified by latex agglutination. The second case had negative CSF culture, but CSF antigen test and gene amplification results were positive for

Identifiants

pubmed: 35928689
doi: 10.3389/fped.2022.945767
pmc: PMC9344131
doi:

Types de publication

Journal Article

Langues

eng

Pagination

945767

Informations de copyright

Copyright © 2022 Rybak, Varon, Masson, Etchevers, Levy-Brühl, Ouldali, Levy and Cohen.

Déclaration de conflit d'intérêts

Grants for ACTIV were received from GlaxoSmithKline (GSK), MSD, Pfizer, and Sanofi outside the submitted work. AR reports grants from AFPA, and travel grants from Pfizer and AstraZeneca outside the submitted work. NO reports travel grants from Pfizer, Sanofi, and GSK, and grants from the European Society for Paediatric Infectious Diseases outside the submitted work. EV reports grants from French Public Health Agency to the institution, and grants to the institution from Pfizer and MSD, outside the submitted work. CL reports grants to the institution ACTIV from GSK, Sanofi, Pfizer, and Merck, and personal fees and nonfinancial support from Pfizer and Merck, outside the conduct of the study. RC reports grants to the institution ACTIV, personal fees, and nonfinancial support from GSK, Sanofi, Pfizer, and Merck, outside the submitted work. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Lancet Infect Dis. 2011 Feb;11(2):119-30
pubmed: 21272792
Lancet Infect Dis. 2004 Mar;4(3):144-54
pubmed: 14998500
Clin Infect Dis. 2005 May 1;40(9):1223-6
pubmed: 15825021
Clin Infect Dis. 2021 Apr 26;72(8):1453-1456
pubmed: 32804200
Clin Infect Dis. 2020 Jan 16;70(3):446-454
pubmed: 30869777
Pediatr Infect Dis J. 2020 Jan;39(1):85-87
pubmed: 31815842
JAMA. 1994 Mar 2;271(9):695-7
pubmed: 8309033
Am J Dis Child. 1990 Aug;144(8):923-7
pubmed: 2378341
Lancet Infect Dis. 2021 Jan;21(1):137-147
pubmed: 32702302
Lancet Glob Health. 2018 Jul;6(7):e744-e757
pubmed: 29903376
Sci Rep. 2018 Aug 21;8(1):12497
pubmed: 30131607
Pediatrics. 2001 May;107(5):E76
pubmed: 11331726
Emerg Infect Dis. 2021;27(8):2240-2241
pubmed: 34287137
Pediatrics. 2008 Aug;122(2):229-37
pubmed: 18676537
J Infect Dis. 1980 Dec;142(6):923-33
pubmed: 7462701
Pediatr Infect Dis J. 2018 Mar;37(3):e72-e78
pubmed: 29227464
Clin Infect Dis. 1999 Nov;29(5):1257-64
pubmed: 10524972
Clin Infect Dis. 2005 May 1;40(9):1215-22
pubmed: 15825020
Clin Infect Dis. 2014 Jul 15;59(2):244-51
pubmed: 24759830

Auteurs

Alexis Rybak (A)

ACTIV, Association Clinique et Thérapeutique Infantile du Val-de-Marne, Créteil, France.
AFPA, Association Française de Pédiatrie Ambulatoire, Orléans, France.
Assistance Publique-Hôpitaux de Paris, Clinical Epidemiology Unit, Robert Debré University Hospital, ECEVE INSERM UMR 1123, Université de Paris, Paris, France.
Assistance Publique-Hôpitaux de Paris, Pediatric Emergency Department, Robert Debré University Hospital, Université de Paris, Paris, France.

Emmanuelle Varon (E)

Université Paris Est, IMRB-GRC GEMINI, Créteil, France.
Laboratory of Medical Biology and National Reference Centre for Pneumococci, Intercommunal Hospital of Créteil, Créteil, France.

Elodie Masson (E)

Assistance Publique-Hôpitaux de Paris, Pediatric Emergency Department, Bicêtre University Hospital, Paris-Saclay University, Le Kremlin-Bicêtre, France.

Anne Etchevers (A)

The National Public Health institute, Saint-Maurice, France.

Daniel Levy-Brühl (D)

The National Public Health institute, Saint-Maurice, France.

Naïm Ouldali (N)

ACTIV, Association Clinique et Thérapeutique Infantile du Val-de-Marne, Créteil, France.
Assistance Publique-Hôpitaux de Paris, Clinical Epidemiology Unit, Robert Debré University Hospital, ECEVE INSERM UMR 1123, Université de Paris, Paris, France.
Assistance Publique-Hôpitaux de Paris, Department of General Pediatrics, Pediatric Infectious Disease and Internal Medicine, Robert Debré University Hospital, Université de Paris, Paris, France.
Infectious Diseases Division, CHU Sainte Justine - Montreal University, Montreal, QC, Canada.

Corinne Levy (C)

ACTIV, Association Clinique et Thérapeutique Infantile du Val-de-Marne, Créteil, France.
AFPA, Association Française de Pédiatrie Ambulatoire, Orléans, France.
Université Paris Est, IMRB-GRC GEMINI, Créteil, France.
Clinical Research Center (CRC), Centre Hospitalier Intercommunal de Créteil, Créteil, France.

Robert Cohen (R)

ACTIV, Association Clinique et Thérapeutique Infantile du Val-de-Marne, Créteil, France.
AFPA, Association Française de Pédiatrie Ambulatoire, Orléans, France.
Université Paris Est, IMRB-GRC GEMINI, Créteil, France.
Clinical Research Center (CRC), Centre Hospitalier Intercommunal de Créteil, Créteil, France.
Neonates Department, Centre Hospitalier Intercommunal de Créteil, Créteil, France.

Classifications MeSH